New study challenges current thinking on risk factors for contrast induced nephrotoxicity

May 1, 2012

Contrary to current belief, a new study finds that patients with a history of diabetes are not one of the most at risk for contrast induced nephrotoxicity. Instead, the study found that patients with a history of renal disease, hypertension and/or heart disease are more likely to suffer from renal insufficiency, putting them at greater risk for contrast induced nephrotoxicity.

The study, done at Northwestern Memorial Hospital-Northwestern University in Chicago, included 2,404 patients. All patients underwent an estimated (eGFR) test immediately before undergoing a CT examination. "Since all patients underwent the eGFR test, we had an unusual opportunity to see if the traditional risk factors truly predict reduced renal function, said Vahid Yaghmai, MD, one of the authors of the study.

The study found that "patients with history of renal disease, hypertension and heart disease had significantly higher odds of having abnormal eGFR," said Dr. Yaghmai. That was not the case for patients with diabetes, he said.

Many facilities ask patients to fill out a survey to help determine if the patients are at risk for contrast induced nephropathy, said Dr. Yaghmai. Based on the survey results, patients most at risk undergo a test to measure their renal function. "Measuring eGFR right before the CT scan can help us more accurately determine at-risk patients. Our results suggest that history of diabetes is not independent predictors of having reduced ," noted Dr. Yaghmai.

The study will be presented May 1, during the 2012 ARRS Annual Meeting in Vancouver, Canada.

Explore further: Common invasive test not necessary for kidney disease patients

Related Stories

Common invasive test not necessary for kidney disease patients

September 15, 2011
Equations that estimate a patient's kidney function work as well as direct, invasive measurements, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology (JASN). This means that ...

Lower contrast agent dose feasible in 320 row CT angiography

October 1, 2011
The analysis of 180 CT angiography studies done using a 320 detector row CT scanner found that a contrast media protocol based on 60 milliliters of iopamidol "had sufficient enhancement in more than 96% of coronary segments," ...

Study identifies novel markers as key indicators of future renal failure in diabetes

January 19, 2012
Scientists at Joslin Diabetes Center have identified two novel markers that, when elevated in the blood stream, can predict accurately the risk of renal (kidney) failure in patients with Type 1 and Type 2 diabetes. The findings ...

Recommended for you

Research examines lung cell turnover as risk factor and target for treatment of influenza pneumonia

July 24, 2017
Influenza is a recurring global health threat that, according to the World Health Organization, is responsible for as many as 500,000 deaths every year, most due to influenza pneumonia, or viral pneumonia. Infection with ...

Scientists propose novel therapy to lessen risk of obesity-linked disease

July 24, 2017
With obesity related illnesses a global pandemic, researchers propose in the Journal of Clinical Investigation using a blood thinner to target molecular drivers of chronic metabolic inflammation in people eating high-fat ...

Raccoon roundworm—a hidden human parasite?

July 24, 2017
The raccoon that topples your trashcan and pillages your garden may leave more than just a mess. More likely than not, it also contaminates your yard with parasites—most notably, raccoon roundworms (Baylisascaris procyonis).

Google searches can be used to track dengue in underdeveloped countries

July 20, 2017
An analytical tool that combines Google search data with government-provided clinical data can quickly and accurately track dengue fever in less-developed countries, according to new research published in PLOS Computational ...

MRSA emerged years before methicillin was even discovered

July 19, 2017
Methicillin resistant Staphylococcus aureus (MRSA) emerged long before the introduction of the antibiotic methicillin into clinical practice, according to a study published in the open access journal Genome Biology. It was ...

New test distinguishes Zika from similar viral infections

July 18, 2017
A new test is the best-to-date in differentiating Zika virus infections from infections caused by similar viruses. The antibody-based assay, developed by researchers at UC Berkeley and Humabs BioMed, a private biotechnology ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.